IP Library Granted Patent US 11,597,921
Granted Patent B2
US 11,597,921 · App. 17/693,233 · Granted Mar 7, 2023

Automated cell processing methods, modules, instruments, and systems

Inventors: Jorge Bernate (Boulder, CO); Kevin Ness (Boulder, CO); Phillip Belgrader (Pleasanton, CA); Don Masquelier (Boulder, CO); Ryan Gill (Boulder, CO)
Assignee: Inscripta, Inc.
C12N15/1082C12M23/44C12M33/14C12M35/00C12M37/04C12M41/36C12M41/48C12M43/00C12N9/22C12N15/11C12Q1/6865C40B40/02C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,597,921
App. No.
17/693,233
Granted
Mar 7, 2023
Kind
B2
Abstract

In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.

Claims (47)

1. An automated stand-alone multi-module cell editing instrument comprising:

a receptacle configured to receive cells;

one or more receptacles configured to receive expression vectors, wherein the expression vectors introduce a desired DNA change to the target region and remove a proto-spacer motif (PAM) region from the target region;

a growth module for growing the cells for transformation;

a cell concentration module to concentrate the cells;

a transformation module configured to introduce nucleic acids into the cells by bead transfection;

a selection module;

a nuclease-directed editing module configured to allow the introduced nucleic acids to edit nucleic acids in the cells using an RNA-guided nuclease;

a processor configured to operate the automated multi-module cell editing instrument based on user input and/or selection of a pre-programmed script; and

an automated liquid handling system to move liquids from the receptacle to the growth module, from the growth module to the cell concentration module, from the cell concentration module to the transformation module, from the transformation module to the selection module, and from the selection module to the nuclease-directed editing module, without user intervention.

2. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the nuclease-directed editing module is also a selection module.

3. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the selection module is separate from the nuclease-directed editing module.

4. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the selection module comprises an antibiotic.

5. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the nuclease-directed editing module is also a recovery module.

6. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the nuclease-directed editing module further comprises a recovery module.

7. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the RNA-guided nuclease is MAD7.

8. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the RNA-guided nuclease editing system is an inducible system.

9. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the growth module is also the cell concentration module.

10. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the growth module is separate from the cell concentration module.

11. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the cell concentration module is also the cell transformation module.

12. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the cell concentration module is separate from the cell transformation module.

13. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the growth module, transformation module and nuclease-directed editing module are combined.

14. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the cell concentration module is combined with the growth module, transformation module and the nuclease-directed editing module.

15. An automated stand-alone multi-module cell editing instrument for RNA-guided editing of mammalian cells comprising:

a receptacle configured to receive mammalian cells;

one or more receptacles configured to receive expression vectors, wherein the expression vectors introduce a desired DNA change to the target region and remove a proto-spacer motif (PAM) region from the target region;

a growth module for growing the mammalian cells for transformation;

a cell concentration module to concentrate the mammalian cells;

a transformation module configured to introduce nucleic acids into the mammalian cells by bead transfection;

a nuclease-directed editing module configured to allow the introduced nucleic acids to edit nucleic acids in the cells using an RNA-guided nuclease;

a processor configured to operate the automated multi-module cell editing instrument based on user input and/or selection of a pre-programmed script; and

an automated liquid handling system to move liquids from the receptacle to the growth module, from the growth module to the cell concentration module, from the cell concentration module to the transformation module, and from the transformation module to the nuclease-directed editing module, without user intervention.

16. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the nuclease-directed editing module is also a selection module.

17. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the receptacle configured to receive mammalian cells is also the growth module.

18. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the nuclease-directed editing module is also a recovery module.

19. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the nuclease-directed editing module further comprises a recovery module.

20. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the RNA-guided nuclease is MAD7.

21. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the RNA-guided nuclease editing system is an inducible system.

22. The automated stand-alone multi-module cell editing instrument of claim 21 , wherein the RNA-guided nuclease editing system is a chemically-inducible system.

23. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the growth module is also the cell concentration module.

24. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the growth module is separate from the cell concentration module.

25. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the cell concentration module is also the cell transformation module.

26. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the cell concentration module is separate from the cell transformation module.

27. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the growth module, transformation module and nuclease-directed editing module are combined.

28. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the receptacle configured to receive mammalian cells is combined with the growth module, transformation module and the nuclease-directed editing module.

29. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the automated liquid handling system comprises a sipper or pipettor.

30. The automated stand-alone multi-module cell editing instrument of claim 15 , wherein the housing is configured to house all of the modules.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2022
From: BERNATE, JORGE; NESS, KEVIN; BELGRADER, PHILLIP; MASQUELIER, DON; GILL, RYAN
To: INSCRIPTA, INC.
Reel/Frame 059247/0001 →
Continuity (28)
Continuation 17538166 · Nov 30, 2021
Continuation 17336244 · Jun 1, 2021
Continuation 17200443 · Mar 12, 2021
Continuation 17131582 · Dec 22, 2020
Continuation 16988694 · Aug 9, 2020
Continuation 16837985 · Apr 1, 2020
Continuation 16822249 · Mar 18, 2020
Continuation 16750369 · Jan 23, 2020
Continuation 16680643 · Nov 12, 2019
Continuation 16666964 · Oct 29, 2019
Continuation 16571091 · Sep 14, 2019
Continuation 16423289 · May 28, 2019
Continuation 16269655 · Feb 7, 2019
Continuation 16024816 · Jun 30, 2018
Provisional Application 62689068 · Jun 23, 2018
Provisional Application 62671385 · May 14, 2018
Provisional Application 62657651 · Apr 13, 2018
Provisional Application 62657654 · Apr 13, 2018
Provisional Application 62649731 · Mar 29, 2018
Provisional Application 62648130 · Mar 26, 2018
Provisional Application 62620370 · Jan 22, 2018
Provisional Application 62567697 · Oct 3, 2017
Provisional Application 62566688 · Oct 2, 2017
Provisional Application 62566375 · Sep 30, 2017
Provisional Application 62566374 · Sep 30, 2017
Provisional Application 62551069 · Aug 28, 2017
Provisional Application 62527339 · Jun 30, 2017
Related Publication 20220195512A1 · Jun 23, 2022